Wiley Matthew T. 4
4 · BioXcel Therapeutics, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Wiley Matthew T.
Other
Transactions
- Award
Common Stock
2024-09-17+21,250→ 25,283 total - Sale
Common Stock
2024-10-03$0.55/sh−6,272$3,450→ 19,011 total
Footnotes (2)
- [F1]The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.